Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
NewGenIvf Group ( (NIVF) ) just unveiled an announcement.
NewGenIvf Group Limited released its unaudited financial results for the six months ending June 30, 2025. The company reported a decrease in revenue compared to the same period in 2024, with a gross profit of $313,804. Despite the revenue decline, NewGenIvf experienced a significant increase in other income, which helped offset its operating loss of $3,240,376. The financial results indicate potential adjustments may occur following the year-end audit, which could impact the reported figures. This announcement highlights the company’s current financial challenges and the importance of its other income streams in maintaining financial stability.
More about NewGenIvf Group
NewGenIvf Group Limited operates in the healthcare industry, focusing on providing in vitro fertilization (IVF) and related fertility services. The company is based in Bangkok, Thailand, and serves a market that includes individuals and couples seeking fertility treatments.
Average Trading Volume: 245,367
Technical Sentiment Signal: Sell
Current Market Cap: $3.85M
For detailed information about NIVF stock, go to TipRanks’ Stock Analysis page.